Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra-operative frozen section.
Karl H TullyMax SchulmeyerJulian HanskeMoritz J ReikeMarko BrockRudolf MoritzHendrik JütteAndrea TannapfelChristian von BodmanJoachim NoldusRein-Jüri PalisaarFlorian RoghmannPublished in: BJU international (2021)
Despite being classified as having a negative surgical margin, patients with residual PCa in the secondary tumour resection specimen face a high risk of BCR. These findings warrant closer post-RP surveillance of this particular subgroup. Further research of this high-risk subset of patients should focus on examining whether these patients benefit from early salvage therapy and how resection status impacts oncological outcomes in the changing landscape of PCa treatment.
Keyphrases
- end stage renal disease
- newly diagnosed
- radical prostatectomy
- prostate cancer
- ejection fraction
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- public health
- type diabetes
- clinical trial
- stem cells
- acute lymphoblastic leukemia
- adipose tissue
- patient reported outcomes
- single cell
- mesenchymal stem cells
- weight loss
- combination therapy